Effects of isoproterenol on myocardial structure and function in septic rats

Journal of Applied Physiology

Volumn 86, Issue 3, 1999, Pages 993-1001

  Piper, R D ^a   Li, F Y ^a   Myers, M L ^a   Sibbald, W J ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Circulation; Heart; Infection; Ischemia reperfusion; Peritonitis

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; ISOPRENALINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASYSTOLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG EFFECT; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; INTRAVENOUS DRUG ADMINISTRATION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SEPSIS; STARLING LAW;

EID: 0033013982     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1999.86.3.993     Document Type: Article

References (42)

1. Allard, M. F., and G. D. Lopaschuk. Ischemia and reperfusion injury in the hypertrophied heart. In: Myocardial Ischemia: Mechanisms, Reperfusion, Protection, edited by M. Karmazyn. Basel: Birkhauser, 1996, p. 423-441.
2. Ash, S. A., and G. E. Griffin. Effect of parenteral nutrition on protein turnover in endotoxaemic rats. Clin. Sci. (Colch.) 76: 659-666, 1989.
3. Barriere, S. L., and S. F. Lowry. An overview of mortality risk prediction in sepsis. Crit. Care Med. 23: 376-393, 1995.
4. Beckman, C. B., Z. Ziazi, R. H. Dietzman, and R. C. Lillehei. Protective effects of epinephrine tolerance in experimental cardiogenic shock. Circ. Shock 8: 137-149, 1981.
5. Bensard, D. D., A. Banerjee, R. C. McIntyre, R. L. Berens, and A. H. Harken. Endotoxin disrupts β-adrenergic signal transduction in the heart. Arch. Surg. 129: 198-205, 1994.
6. Bergmeyer, H. U. Methods in Enzymatic Analysis. New York: Academic, 1963.
7. Boluyt, M. O., X. Long, T. Eschenhagen, U. Mende, W. Schmidt, M. T. Crow, and E. G. Lakatta. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H638-H647, 1995.
8. Currie, R. W., R. M. Tanguay, and J. G. Kingma, Jr. Heat-shock response and limitation of tissue necrosis during occlusion/reperfusion in rabbit hearts. Circulation 87: 963-971, 1993.
9. Dusek, J., G. Rona, and D. S. Kahn. Myocardial resistance. A study of its development against toxic doses of isoproterenol. Arch. Pathol. 89: 79-83, 1970.
10. Fessler, H. E., L. Otterbein, H. S. Chung, and A. M. Choi. Alpha-2 adrenoceptor blockade protects against lipopolysaccharide. Am. J. Respir. Crit. Care Med. 154: 1689-1693, 1996.
11. Fisher, D. G., P. H. Schwartz, and A. L. Davis. Pharmacokinetics of exogenous epinephrine in critically ill children. Crit. Care Med. 21: 111-117, 1993.
12. Handforth, C. P. Isoproterenol-induced myocardial infarction in animals. Arch. Pathol. 73: 161-165, 1962.
13. Hayes, M. A., A. C. Timmins, E. H. Yau, M. Palazzo, C. J. Hinds, and D. Watson. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N. Engl. J. Med. 330: 1717-1722, 1994.
14. Horton, J. W., and D. J. White. Cardiac contractile injury after intestinal ischemia-reperfusion. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H1164-H1170, 1991.
15. Irlbeck, M., O. Muhling, T. Iwai, and H. G. Zimmer. Different response of the rat left and right heart to norepinephrine. Cardiovasc. Res. 31: 157-162, 1996.
16. Jiang, J. P., and S. E. Downing. Catecholamine cardiomyopathy: review and analysis of pathogenic mechanisms. Yale J. Biol. Med. 63: 581-591, 1990.
17. i elevation and ATP depletion. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H9-H16, 1990.
18. Kovarik, M. F., S. B. Jones, and F. D. Romano. Plasma catecholamines following cecal ligation and puncture in the rat. Circ. Shock 22: 281-290, 1987.
19. Laine, G. A., and S. J. Allen. Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ. Res. 68: 1713-1721, 1991.
20. Laks, M. M., F. Morady, and H. J. Swan. Myocardial hypertrophy produced by infusion of subhypertensive doses of norephinephrine in the dog. Chest 64: 75-78, 1973.
21. Macallan, D. C. and G. E. Griffin. Cardiac muscle protein gene expression in the endotoxin-treated rat. Clin. Sci. (Colch.) 87: 539-546, 1994.
22. McDonough, K. H., and K. M. Causey. Effects of sepsis on recovery of the heart from 50 min ischemia. Shock 1: 432-437, 1994.
23. Morisaki, H., W. Sibbald, C. Martin, G. Doig, and K. Inman. Hyperdynamic sepsis depresses circulatory compensation to normovolemic anemia in conscious rats. J. Appl. Physiol. 80: 656-664, 1996.
24. Nino, A. F., M. M. Berman, E. H. Gluck, M. M. Conway, J. P. Fisher, J. E. Dougherty, and M. A. Rossi. Drug-induced left ventricular failure in patients with pulmonary disease. Endomyocardial biopsy demonstration of catecholamine myocarditis. Chest 92: 732-736, 1987.
25. Parker, M. M., J. H. Shelhamer, S. L. Bacharach, M. V. Green, C. Natanson, T. M. Frederick, B. A. Damske, and J. E. Parrillo. Profound but reversible myocardial depression in patients with septic shock. Ann. Intern. Med. 100: 483-490. 1984.
26. Piper, R. D., F. Li, M. L. Meyers, and W. J. Sibbald. Structure function relationships in the septic heart. Am. J. Respir. Crit. Care Med. 156: 1473-1482, 1997.
27. Raum, W. J., M. M. Laks, D. Garner, M. H. Ikuhara, and R. S. Swerdloff. Norephinephrine increases β-receptors and adenylate cyclase in canine myocardium. Am. J. Physiol. 246 (Heart Circ. Physiol. 15): H31-H36, 1984.
28. Reichenbach, D. D., and E. P. Benditt. Myofibrillar degeneration. A response of the myocardial cell to injury. Arch. Pathol. 85: 189-199, 1968.
29. Rona, G., C. I. Chappel, T. Balazs, and R. Gaudry. An infarct like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch. Pathol. 67: 443-445, 1959.
30. Selye, H., R. Veilleux, and S. Grasso. Protection, by coronary ligature, against isoproterenol-induced myocardial necroses. Proc. Soc. Exp. Biol. Med. 104: 343-345, 1960.
31. Stanton, H. C., G. Brenner, and E. D. Mayfield, Jr. Studies on isoproterenol-induced cardiomegaly in rats. Am. Heart J. 77: 72-80, 1969.
32. Steare, S. E., and D. M. Yellon. The potential for endogenous myocardial antioxidants to protect the myocardium against ischemia-reperfusion injury: refreshing the parts exogenous antioxidants cannot reach? J. Mol. Cell. Cardiol. 27: 65-74, 1995.
33. Streat, S. J., A. H. Beddoe, and G. L. Hill. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J. Trauma 27: 262-266, 1987.
34. Takeda, S., T. Satoh, M. Osada, S. Komori, S. Mochizuki, and K. Tamura. Protective effect of pacing on reperfusion-induced ventricular arrhythmias in isolated rat hearts. Can. J. Cardiol. 11: 573-579, 1995.
35. Takeo, S., J. X. Liu, K. Tanonaka, Y. Nasa, K. Yabe, H. Tanahashi, and H. Sudo. Reperfusion at reduced flow rates enhances postischemic contractile recovery of perfused heart. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2384-H2395, 1995.
36. Tse, J., N. L. Brackett, and J. F. Kuo. Alterations in activities of cyclic nucleotide systems and in beta-adrenergic receptor-mediated activation of cyclic AMP-dependent protein kinase during progression and regression of isoproterenol-induced cardiac hypertrophy. Biochim. Biophys. Ada 542: 399-411, 1978.
37. Vary, T. C., and S. R. Kimball. Sepsis-induced changes in protein synthesis: differential effects on fast- and slow-twitch muscles. Am. J. Physiol. 262 (Cell Physiol. 31): C1513-C1519, 1992.
38. Vegh, A., J. G. Papp, and J. R. Parratt. Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br. J. Pharmacol. 113: 1081-1082, 1994.
39. Werner, H. A., M. J. Herbertson, and K. R. Walley. Amrinone increases ventricular contractility and diastolic compliance in endotoxemia. Am. J. Respir. Crit. Care Med. 152: 496-503, 1995.
40. Yates, J. C., and N. S. Dhalla. Induction of necrosis and failure in the isolated perfused heart with oxidized isoproterenol. J. Mol. Cell. Cardiol. 7: 807-816, 1975.
41. Yellon, D. M., and G. F. Baxter. A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection?. J. Mol. Cell. Cardiol. 27: 1023-1034, 1995.
42. Zierhut, W., and H. G. Zimmer. Significance of myocardial en- and β-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ. Res. 65: 1417-1425, 1989.